Afrigen Biologics Announces RSV mRNA Vaccine Collaboration with RespIP BV

Healthbridgers and Schuttelaar & Partners Join Forces to Advance Sustainable Healthcare Pathways

Greywolf Therapeutics appoints Edwin Moses as Chair

Khondrion Announces First Patient Dosed in Pivotal Phase 3 KHENERFIN Study of Sonlicromanol in Mitochondrial DNA 3243A>G Primary Mitochondrial Disease

PamDx Secures €13 Million Series A Funding to Advance Deployment of Diagnostic Blood Tests for Cancer Patients Treated with Immunotherapy

Utrecht scientists reveal that metastasis-related changes occur early in colon cancer

TIBEAY Biosciences raises EUR 35 million for a Phase 3b trial of Ronopterin in traumatic brain injury

An important step forward in the fight against antimicrobial resistance (AMR)

ProQR Announces Partnership with Ginkgo Bioworks and Formation of AI Advisory Board